Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects the brain in adult patients who typically remain asymptomatic for a considerable duration of time before demonstrating clinical evidence of cognitive decline. 1, 2 Cerebral amyloid angiopathy (CAA) is commonly observed in pathology analysis of AD-affected brains and it is associated with lobar distribution of cerebral microbleeds (CMBs), which affect cognitive function. [3] [4] [5] CMBs are presumed to reflect focal hemosiderin deposits in the brain that are caused by leakage of red blood cells from small blood vessels. 6, 7 CMBs can be visualized on T2*-weighted gradientrecalled-echo (GRE) magnetic resonance (MR) imaging sequences, as small foci of decreased signal intensity. 3, 8 In recent years, the introduction of susceptibilityweighted imaging (SWI) MR sequences has improved CMB detection in MR imaging. 1 
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The SWI sequence is a velocity compensated highresolution 3D gradient-echo sequence that uses magnitude and filtered-phase information to create a new contrast. [9] [10] [11] As a result, CMBs are more sensitively detected by SWI compared with T2*-weighted GRE. 3, [12] [13] [14] A previous study 4 based on 3 T MR imaging and T2* GRE sequence demonstrated an association between lobar distributed CMBs and cerebrospinal fluid (CSF) amyloid-beta (A) levels as well as with CSF phosphorylated tau 181 protein (p-tau) levels and the presence of cognitive decline in AD patients.
The aim of this study was to assess the presence and distribution of CMBs with SWI MR sequences implemented in a more widely available 1.5 T MR unit and to correlate the presence and distribution of CMBs with CSF biomarkers of AD and with cognitive decline in AD patients.
Material and methods

Patient population
We included 54 consecutive patients (20 men, 34 women; mean age: 76.8 AE 5.2 years) diagnosed as having AD (mean duration of the disease: 7.2 AE 3.7 years).
The diagnosis was established according to the criteria for probable AD as proposed by the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association. 15 Exclusion criteria were: previous stroke or head trauma; cancer history; severe cardiac, renal, or hepatic disease; recent history of infection or inflammatory disease. Dementia severity was assessed with the Mini-Mental State Examination. 16 Demographic data are presented in Table 1 .
Patients underwent lumbar puncture to obtain CSF samples for quantifying levels of CSF A and p-tau.
The institutional review board of our institution approved this retrospective study and written informed consent was obtained from all patients. Susceptibility weighted imaging (SWI) sequences were obtained using a technique that combines a long-TE high-resolution fully flow-compensated 3D GRE sequence with filtered phase information in each voxel, as previously described. [9] [10] [11] The SWI images (3D GRE 24/34 [TR/TE], flip angle 10 ) were obtained with a FOV of 22 cm, matrix 256 Â 512, slice thickness 1.2 mm, gap 0 mm, number of excitations 1 and acquisition time 5.15 min. Subsequently, the SWI sequences were reconstructed to obtain images of 5 mm thickness, 1 mm intersection gap, oriented in the axial plane similar to that of FSE images.
MR imaging
Calcifications of the basal ganglia and deep cerebellar nuclei were considered as normal findings if present and not taken into account during the review of the images. None of the patients had disorders of calcium/phosphate metabolism.
Image analysis
The images were analyzed in consensus by two neuroradiologists, each with at least 10 years experience.
Images, presented in random order, were analyzed for the presence and location of the CMB lesions.
CMBs were defined as small hypointense lesions within the brain parenchyma that measured less than 10 mm on the SWI images.
The locations of the microbleeds were subdivided into: non-lobar, if located in the basal ganglia, thalami, brain stem, or cerebellum; lobar, if located in one of the four cerebral lobes: frontal, parietal, occipital, and temporal; mixed, in the case of CMBs distributed in both lobar and non-lobar locations.
The two neuroradiologists recorded the location and number of lesions seen on SWI images on a PACS system (Agfa HealthCare GmbH -Bonn).
Statistical analysis
The ordinary least-squares multiple regression analysis was performed to assess the associations between the number and location of CMB lesions (dependent variable) with the patient's age and sex, duration of the disease, CSF A, p-tau levels, and cognitive functions (independent variables). Differences for a P value of < .05 were considered statistically significant. Statistical analysis was performed using the statistical software package SPSS (SPSS, Chicago, IL). 
Results
CMBs were demonstrated as small, rounded, hypointense lesions within the brain parenchyma that measured less than 10 mm on the SWI images. A total of 296 microbleeds were observed in 54 patients; 38 patients (70.4%) had lobar distribution, 13 patients (24.1%) had non-lobar distribution and the remaining three patients (5.6%) had mixed distribution (see Table 2 and Figures 1-3) .
The mean count of microbleeds was 5.4 per patient and the median was four CMBs per patient. The frequency of the number of CMBs was as follow: seven patients (13%) had one microbleed, 11 patients (20.4%) had two microbleeds, eight patients (14.8%) had three microbleeds, eight patients (14.8%) had four microbleeds, four patients (7.4%) had five microbleeds and the remaining 16 patients (29.6%) had more than five microbleeds ( Table 3) .
The correlation analysis showed that the age of the patients and the duration of the disease were significantly correlated with the number of lobar CMBs (P < 0.001, age coefficient .46, duration of the disease coefficient .58).
A significant correlation was found between the CSF A levels and the number of lobar CMBs (P < 0.001, coefficient À.32). Non-lobar microbleeds were not associated with CSF A levels.
A direct correlation was found between the number of lobar CMBs and CSF p-tau levels (P < 0.001, coefficient .35).
Non-lobar microbleeds were not correlated with CSF p-tau levels.
Using a generalized linear mixed-effects model adjusted for covariates, including CSF A levels, age, sex, and disease duration, the number of lobar microbleeds was significantly associated with the MMSE score (P < 0.001, coefficient À.37).
Non-lobar microbleeds were not associated with change in MMSE score (P < 0.001). Results are summarized in Table 4 .
Discussion
The results of our study confirm that lobar distribution of microbleeds is associated with AD as reported in previous publications. 17, 18 In particular, of the 54 AD patients reviewed, 38 (70.4%) had a lobar distribution of the microbleeds, 13 (24.1%) had a non-lobar distribution and the remaining three (5.6%) had a mixed distribution ( Table 2 ).
In accordance with results of previous publications, which showed lower CSF A levels in AD patients with lobar microbleeds, 4, 19, 20 we likewise found a significant correlation between CSF A levels and the number of lobar CMBs (P < 0.001, coefficient À.32), which means 
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The Neuroradiology Journal 30(4) that greater brain amyloidosis is associated with increasing numbers of lobar CMBs. It should be noted that previous investigators 4 were unable to establish statistical significance for this correlation. A possible explanation for the significant correlation found in our study may relate to a substantial technical difference between the studies, as we used SWI sequences as opposed to the T2* GRE sequences used by others. SWI sequences have been demonstrated to be superior to T2* GRE sequences, the former having higher sensitivity in demonstrating CMBs. 21, 22 Such increased sensitivity of SWI for visualization of CMBs probably leads to detection of a greater number of microbleeds in our study and thus accounts for the statistically significant correlation with the lower CSF A levels observed in our AD patients.
An association between lobar microbleeds and elevated CSF p-tau level was also demonstrated (P < 0.001, coefficient .35), implying that a larger number of lobar CMBs are observed in patients with higher CSF p-tau levels. This correlation may reflect the notion that microbleeds are the imaging expression of damaged microvasculature, or that CMBs may lead to cerebral inflammation, which results in increased tau pathology. 4, 23 Non-lobar microbleeds were not associated with CSF A and p-tau levels.
The patient's age and the duration of the disease were correlated with the number of lobar CMBs (P < 0.001, age coefficient .46, duration of the disease coefficient .58), and a correlation analysis adjusted for CSF A levels, age, sex, and duration of the disease showed that the number of lobar microbleeds was significantly associated with the MMSE score, implying that worsening cognitive function is associated with the presence and number of lobar CMBs (P < 0.001, coefficient À.37).
This result confirms conclusions reached by previous publications which have shown a direct correlation between the extent of amyloid angiopathy and the degree of memory and cognitive decline in AD patients with lobar microbleeds. 4, 18, 24, 25 Non-lobar microbleeds were not associated with change in MMSE score (P < 0.001), as demonstrated in previous studies. 4, 26 One of the limitations of our study is that it lacked a comparison between T2* GRE sequences and SWI sequences in the detection of CMBs. However, this aspect was beyond the purpose of our study, as the higher sensitivity of SWI sequences for detection of CMBs had already been demonstrated by several previous publications. 21, 22 Conclusion Improved detection of CMBs with SWI sequences may contribute to more accurate identification of AD patients, who typically present a lobar distribution of CMBs.
The number of lobar CMBs is correlated to CSF A and p-tau levels and with the degree of cognitive decline of AD patients.
Our results should be carefully evaluated as our sample population was relatively homogeneous, resulting in limited generalizability, and further validation in a larger prospective population is required. 
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